Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prediction of LVAR and MACE in AMI Though Plasma Multiomics Analysis
Sponsor: Beijing Anzhen Hospital
Summary
To identify plasma multi-omics biomarkers that predict left ventricular adverse remodeling (LVAR) and major adverse cardiovascular events (MACE) in patients with acute myocardial infarction, and to investigate the molecular pathways linked to LVAR and MACE.
Official title: Prediction of Left Ventricular Adverse Remodeling and Major Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction Though Plasma Multiomics Analysis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-01-01
Completion Date
2027-12-31
Last Updated
2025-07-31
Healthy Volunteers
No
Conditions
Interventions
Diagnostic Test: echocardiography and blood collection
Blood samples were collected from all patients at the time of myocardial infarction (MI) diagnosis. For those with acute ST-elevation myocardial infarction, blood samples were taken on the day of diagnosis(T0), as well as two days (T1), one week (T2) and one month (T3) after percutaneous coronary intervention (PCI). Echocardiography was performed at the time of STEMI diagnosis, and then again at one week, one month, and six months post-onset.
Locations (1)
Beijing Anzhen Hospital, Capital Medical University.
Beijing, Beijing Municipality, China